Stockscreener 앱 받기
178.91
0.51%
0.64
Becton Dickinson Co 주식(BDX)의 최신 뉴스
$7.80 Billion by 2030: Why Single-Use Surgical Instruments Are Reshaping Global Surgery | MarketsandMarkets™ - GlobeNewswire Inc.
BD issues voluntary recall on certain Alaris infusion pump modules - MassDevice
BD issues update to recall of Alaris & BD Alaris pump modules - MarketScreener
BD to spin off biosciences, diagnostics businesses in $17.5B deal (updated) - NJBIZ
Becton Dickinson and : BD Issues Update to Voluntary Global Recall of Alaris™ and BD Alaris™ Pump Modules Serviced with Legacy Bezel Kit Assemblies - MarketScreener
Becton Dickinson stock holds steady as TD Cowen maintains $183 price target - Investing.com Nigeria
Becton, Dickinson & Co (BDX) Is Paying a $85M Settlement to Investors — Here’s How to Get Your Share - TradingView
Becton, Dickinson and Company (BDX) Traded Down on Weak Earnings - Insider Monkey
Becton Dickinson’s Hold Rating Amid Strategic Moves and Limited Immediate Upside - TipRanks
Waters, BD’s Biosciences & Diagnostic Solutions to combine - Medical Buyer
A Big Move By Waters Corporation And Becton, Dickinson And Company (NYSE:WAT) - Seeking Alpha
BD’s biosciences & diagnostics unit in $17.5B merger with Waters - BioWorld MedTech
$17.5B Deal Combines Waters with BD’s Biosciences and Diagnostics Business - Genetic Engineering and Biotechnology News
Becton Dickinson Announces Reverse Morris Trust with Waters - TipRanks
Becton Dickinson Finds a Partner for Its Biosciences and Diagnostics Business in Waters - Morningstar
Milford’s Waters Corp. strikes $17.5 billion deal to merge with BD’s diagnostics unit - The Boston Globe
Waters to buy Becton Dickinson unit in a $17.5 billion deal amid tariff pressures - CNBC
Waters, BD Unite in $17.5B Diagnostics Deal - USA Herald
Waters, BD Biosciences & Diagnostic Solutions to combine in $17.5B deal - MassDevice
Analytics Equipment Maker Waters Buys Becton Dickinson Unit in a $17.5B Deal - Yahoo Finance
Waters inks $17.5B merger with division of BD - The Business Journals
Becton Dickinson Spins Off Biosciences In $17.5 Billion Waters Deal - Finimize
Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - The Wall Street Journal
Waters, BD Biosciences & Diagnostic Solutions to Merge in $17.5B Deal - Medical Product Outsourcing
Here’s Why Becton, Dickinson and Company (BDX) Traded Lower in Q2 - Insider Monkey
Why is Waters Stock Down On Monday?Becton Dickinson (NYSE:BDX), Waters (NYSE:WAT) - Benzinga
Becton Dickinson gets its spinoff deal, but the stock is still falling - MarketWatch
Becton, Dickinson and Company (BDX) Announces Strategic Merger w - GuruFocus
Waters and BD’s Biosciences & Diagnostic Solutions Business To Merge - citybiz
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing - Placera.se
Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal - MarketScreener
Waters to Create $6.5B Life Sciences Giant Through $17.5B Merger with BD Biosciences Division - Stock Titan
Becton, Dickinson and Co. Advances with SiteRite 9 Ultrasound System Study - TipRanks
BD to acquire Bard - The Covington News
BD Appoints Bilal Muhsin as EVP and President of Future Connected Care Segment - citybiz
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment - MarketScreener
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment, Effective July 2 - MarketScreener
Wells Fargo Remains a Hold on Becton Dickinson (BDX) - The Globe and Mail
Becton, Dickinson and Co Completes Key Study on HPV Diagnostic Kit - TipRanks
Becton, Dickinson General Counsel to Be Medtronic Top Lawyer (1) - Bloomberg Law News
Becton, Dickinson and Co’s Latest Study on Male Incontinence Solutions: Market Insights - TipRanks
Becton, Dickinson and Company (BDX): A Bull Case Theory - Insider Monkey
YieldBoost Becton, Dickinson From 2.5% To 15.5% Using Options - Nasdaq
BD upgrades laboratory in Suzhou - China Daily
Investors Can Still File Late Claims in BDX Settlement — Here’s How to Get Your Share - TradingView
Becton Dickinson’s SWOT analysis: medical giant’s stock faces pivotal shift - Investing.com
Becton Dickinson’s SWOT analysis: medical giant’s stock faces pivotal shift By Investing.com - Investing.com India
Becton Dickinson Stock Price, Quotes and Forecasts | NYSE:BDX - Benzinga
Medical technology firm BD looks to bring products to more PHL hospitals - BusinessWorld Online
Becton Dickinson at Goldman Sachs Conference: Strategic Moves Ahead By Investing.com - Investing.com South Africa
Becton Dickinson at Goldman Sachs Conference: Strategic Moves Ahead - Investing.com Australia
Becton, Dickinson And Co To Present At Goldman Sachs Conference; Webcast At 2:00 PM ET - Nasdaq
Stifel maintains Becton Dickinson stock with a $224 target - Investing.com
Here's How You Can Earn $100 In Passive Income By Investing In Becton Dickinson Stock - Yahoo Finance
Barclays Lowers Becton, Dickinson & Co. (BDX) Price Target, Maintains Overweight Rating - MSN
BD’s Future Plans: Shed Life Sciences to Fund Medical Technology - Lab Manager
How Is Becton, Dickinson and Company’s Performance Compared to Other Medical Instruments & Supplies Stocks? - Barchart.com
Becton Dickinson (BDX) Maintains Overweight Rating Despite Price Target Cut | BDX Stock News - GuruFocus
0.37%
0.00%
자본화:
|
볼륨(24시간):